Is KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Halal?

NASDAQ Healthcare United States $1.1B
✗ NOT HALAL
Confidence: 90/100
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 5.35% exceeds the 5% threshold allowed under AAOIFI. KESTRA MEDICAL TECHNOLOGIES, LTD. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from April 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 3.3%
/ 30%
17.7%
/ 30%
0.6%
/ 30%
5.35%
/ 5%
✗ NOT HALAL
DJIM 3.3%
/ 33%
17.7%
/ 33%
0.6%
/ 33%
5.35%
/ 5%
✗ NOT HALAL
MSCI 15.0%
/ 33%
80.3%
/ 33%
2.7%
/ 33%
5.35%
/ 5%
✗ NOT HALAL
S&P 3.3%
/ 33%
17.7%
/ 33%
0.6%
/ 33%
5.35%
/ 5%
✗ NOT HALAL
FTSE 15.0%
/ 33%
80.3%
/ 33%
2.7%
/ 50%
5.35%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-5.46
P/B Ratio
3.9
EV/EBITDA
-6.6
EV: $891M
Revenue
$60M
Growth: 62.7%
Current Ratio
7.3

Profitability

Gross Margin 48.8%
Operating Margin -141.6%
Net Margin -173.0%
Return on Equity (ROE) -92.7%
Return on Assets (ROA) -36.8%

Cash Flow & Balance Sheet

Operating Cash Flow-$78M
Free Cash Flow-$101M
Total Debt$44M
Debt-to-Equity16.2
Current Ratio7.3
Total Assets$296M

Price & Trading

Last Close$19.68
50-Day MA$23.59
200-Day MA$22.07
Avg Volume330K
52-Week Range
$13.25
$30.00

About KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

CEO
Mr. Brian Webster
Employees
330
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$1.1B
Currency
USD

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), KESTRA MEDICAL TECHNOLOGIES, LTD. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is KESTRA MEDICAL TECHNOLOGIES, LTD.'s debt ratio?

KESTRA MEDICAL TECHNOLOGIES, LTD.'s debt ratio is 3.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 15.0%.

What are KESTRA MEDICAL TECHNOLOGIES, LTD.'s key financial metrics?

KESTRA MEDICAL TECHNOLOGIES, LTD. has a market capitalization of $1.1B, and revenue of $60M. The company maintains a gross margin of 48.8% and a net margin of -173.0%. Return on equity stands at -92.7%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.